A detailed history of Carlton Hofferkamp & Jenks Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Carlton Hofferkamp & Jenks Wealth Management, LLC holds 10,386 shares of ABBV stock, worth $1.87 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
10,386
Previous 10,591 1.94%
Holding current value
$1.87 Million
Previous $1.82 Million 12.94%
% of portfolio
0.67%
Previous 0.74%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$163.84 - $199.33 $33,587 - $40,862
-205 Reduced 1.94%
10,386 $2.05 Million
Q2 2024

Jul 31, 2024

BUY
$154.79 - $180.76 $3,560 - $4,157
23 Added 0.22%
10,591 $1.82 Million
Q1 2024

Apr 26, 2024

BUY
$159.82 - $182.1 $6,872 - $7,830
43 Added 0.41%
10,568 $1.92 Million
Q3 2023

Oct 26, 2023

BUY
$133.59 - $154.65 $10,019 - $11,598
75 Added 0.72%
10,525 $1.57 Million
Q2 2023

Aug 07, 2023

BUY
$132.51 - $164.9 $1,325 - $1,649
10 Added 0.1%
10,450 $1.41 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $48,155 - $55,457
-333 Reduced 3.09%
10,440 $1.66 Million
Q4 2022

Jan 30, 2023

SELL
$138.31 - $165.87 $9,958 - $11,942
-72 Reduced 0.66%
10,773 $1.74 Million
Q3 2022

Oct 24, 2022

SELL
$134.21 - $153.93 $8,723 - $10,005
-65 Reduced 0.6%
10,845 $1.6 Million
Q2 2022

Jul 12, 2022

BUY
$137.62 - $174.96 $3,440 - $4,374
25 Added 0.23%
10,910 $1.67 Million
Q1 2022

Apr 11, 2022

SELL
$131.98 - $163.75 $36,162 - $44,867
-274 Reduced 2.46%
10,885 $1.9 Million
Q4 2021

Jan 26, 2022

SELL
$107.43 - $135.93 $15,040 - $19,030
-140 Reduced 1.24%
11,159 $1.49 Million
Q3 2021

Nov 09, 2021

BUY
$106.4 - $120.78 $50,114 - $56,887
471 Added 4.35%
11,299 $1.31 Million
Q2 2021

Jul 19, 2021

SELL
$105.21 - $117.21 $7,259 - $8,087
-69 Reduced 0.63%
10,828 $1.27 Million
Q1 2021

Apr 28, 2021

BUY
$102.3 - $112.62 $89,512 - $98,542
875 Added 8.73%
10,897 $1.21 Million
Q4 2020

Jan 20, 2021

SELL
$80.49 - $108.67 $36,220 - $48,901
-450 Reduced 4.3%
10,022 $1.12 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $168,984 - $198,332
1,967 Added 23.13%
10,472 $1.03 Million
Q2 2020

Jul 30, 2020

BUY
$73.37 - $98.18 $24,505 - $32,792
334 Added 4.09%
8,505 $825,000
Q1 2020

Apr 30, 2020

BUY
$64.5 - $97.79 $101,007 - $153,139
1,566 Added 23.71%
8,171 $684,000
Q4 2019

Jan 28, 2020

BUY
$72.13 - $90.25 $32,530 - $40,702
451 Added 7.33%
6,605 $555,000
Q3 2019

Oct 11, 2019

BUY
$62.98 - $75.72 $94,470 - $113,580
1,500 Added 32.23%
6,154 $458,000
Q2 2019

Jul 18, 2019

BUY
$65.7 - $83.98 $55,253 - $70,627
841 Added 22.06%
4,654 $318,000
Q1 2019

Apr 22, 2019

BUY
$77.14 - $90.79 $60,632 - $71,360
786 Added 25.97%
3,813 $307,000
Q4 2018

Jan 29, 2019

BUY
$77.85 - $96.01 $235,651 - $290,622
3,027 New
3,027 $279,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Carlton Hofferkamp & Jenks Wealth Management, LLC Portfolio

Follow Carlton Hofferkamp & Jenks Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carlton Hofferkamp & Jenks Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carlton Hofferkamp & Jenks Wealth Management, LLC with notifications on news.